|
Volumn 481, Issue 2, 2000, Pages 137-140
|
Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes
|
Author keywords
Anticancer drug; Electrophysiology; HCNT1; Nucleoside
|
Indexed keywords
CARRIER PROTEIN;
FLUDARABINE;
GEMCITABINE;
NUCLEOSIDE TRANSPORTER 1;
UNCLASSIFIED DRUG;
URIDINE;
ANIMAL CELL;
ARTICLE;
DRUG PROTEIN BINDING;
DRUG UPTAKE;
HYPERPOLARIZATION;
NONHUMAN;
NUCLEOSIDE TRANSPORT;
NUCLEOTIDE SEQUENCE;
OOCYTE;
PRIORITY JOURNAL;
SODIUM CURRENT;
VOLTAGE CLAMP;
XENOPUS LAEVIS;
ANIMAL;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTIVIRAL AGENTS;
CARRIER PROTEINS;
CYTIDINE;
DEOXYCYTIDINE;
ELECTRIC CONDUCTIVITY;
GENE EXPRESSION;
HUMAN;
MEMBRANE POTENTIALS;
MEMBRANE PROTEINS;
NUCLEOSIDE TRANSPORT PROTEINS;
NUCLEOSIDES;
OOCYTES;
SODIUM;
SUBSTRATE SPECIFICITY;
SUPPORT, NON-U.S. GOV'T;
URIDINE;
VIDARABINE;
XENOPUS LAEVIS;
XENOPUS LAEVIS;
|
EID: 0034666069
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(00)01983-9 Document Type: Article |
Times cited : (57)
|
References (21)
|